Recent Headlines
Sentynl Therapeutics, Inc. Acquires Abstral®
Sentynl Therapeutics, Inc. (“Sentynl”) announced that it acquired the rights to market Abstral® in the U.S. from Galena Biopharma. Abstral® is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Welcomes Darren Pincus as Vice President of Business Development
Sentynl Therapeutics, Inc. (“Sentynl”) announced that Darren Pincus joined Sentynl as its Vice President and head of Business Development. Mr. Pincus is a highly experienced business development professional with a strong track record of successfully completed transactions. Prior to... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Launches Sentynl Patient Services
Sentynl Therapeutics, Inc. (“Sentynl”) announced that it launched Sentynl Patient Services to enhance patient access to its products. Sentynl Patient Services provides support to patients who want assistance with investigating their benefits, affording their medications and locating... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Launches Its Commercial Organization
Sentynl Therapeutics, Inc. (“Sentynl”) announced that it launched its commercial organization including a full-time, professional sales force of key account specialists. About Sentynl Therapeutics. Sentynl provides healthcare professionals with treatment solutions that enable them to... - April 30, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Welcomes Michael Hercz as Its Senior Vice President and General Counsel
Sentynl Therapeutics, Inc. (“Sentynl”) announced that Michael Hercz joined Sentynl as its Senior Vice President, General Counsel and Chief Compliance Officer. Mr. Hercz brings more than 18 years of legal, compliance and risk management experience to Sentynl. Prior to Sentynl, Mr. Hercz... - April 30, 2016 - Sentynl Therapeutics, Inc.
Compounding Pharmacy Supplies Medication for Study Using Edetate Disodium Therapy
Following the generally positive outcome of the National Institutes of Health-funded Trial to Assess Chelation Therapy (TACT)[1] study completed in 2012, it was decided that further research was warranted to test the safety and effectiveness of Chelation therapy as a treatment option for... - April 27, 2016 - Universal Arts Compounding Pharmacy
ALPCO’s Bioactive Leptin ELISA Allows Researchers to Differentiate Between Leptin Resistance and Non-functional Leptin
ALPCO recently announced the release of its Bioactive Leptin ELISA, offering diabetes and obesity researchers a new tool to differentiate between leptin resistance and non-functional leptin. The assay allows for the measurement of leptin in human serum through the process of binding leptin to... - April 26, 2016 - ALPCO
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study - The Reanima Project - Is Death Reversible? - April 25, 2016 - Bioquark Inc.
Morgan's Fund Issues Statement on Selection for NORD's Natural History Studies Project
A statement was issued today by Stephanie M. Vaughan, Co-founder and President of The Morgan Leary Vaughan Fund (Morgan’s Fund), regarding the announcement of the National Organization for Rare Disorders’ (NORD) selection of Natural History Studies Project participants. - April 22, 2016 - The Morgan Leary Vaughan Fund, Inc.
ValueCentric’s Order Management Module Becomes Choice Solution for Top Pharma Manufacturers
ValueCentric, the industry leader in healthcare channel intelligence, announced today that their Order Management application surpassed a significant milestone of $200 billion in processed orders annually. Following two recent implementations, the company is now processing critical order data for... - April 22, 2016 - ValueCentric
Hypoxia Inducible Factor (HIF) Inhibitors - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Hypoxia Inducible Factor (HIF) Inhibitors - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this their research expertise provides their clients with up to date information of market till date order has been placed. - April 16, 2016 - DelveInsight
Montana Molecular Appoints MoBiTec, Germany, as Distributor to Sell Genetically Encoded Fluorescent Biosensors
While fluorescent dye-based assays are powerful tools for high-throughput screening in engineered cell lines or cell lysates to show that signaling has occurred, genetically encoded sensors that measure dynamic processes in physiologically relevant cells provide a higher level of insight into how signals are regulated in both space and time. It is the regulation of signaling that controls cell function in both health and disease. - April 16, 2016 - MoBiTec GmbH
The New York Center for Nanomedicine Research, Inc. is Signing a Strategic Agreement to Provide Drug Delivery Systems to ICAHRIS in Canada
Strategic agreement for the development of nanoparticules with application in Cancer, Type 2 diabetes and inflammation. The NYCNMR is providing to ICAHRIS, its innovative platform dedicated to Nanomedicine. The NY center is located in the upcoming Bio-Cluster located in Buffalo NY. - April 14, 2016 - New York Center for Nanomedicine Research, Inc.
BreviTest Awarded Grant from National Institute on Drug Abuse to Optimize Device for Rapid Cannabis Testing
BreviTest Technologies has been awarded a $234,412 grant from the National Institute on Drug Abuse of the National Institutes of Health (NIH) to explore rapid testing for THC, the main active ingredient in cannabis. The federal funds, awarded under the NIH’s Small Business Innovation Research... - April 14, 2016 - Cayman Chemical Company
Biomedical Strategy Expert Brett Giroir Joins Noninvasix Scientific Advisory Board
Medical device firm Noninvasix, Inc., developers of a patient monitoring system that accurately and noninvasively measures the amount of brain oxygenation in preterm infants, announced today that life science strategy expert Brett Giroir, M.D. has been appointed to the company’s Scientific... - April 13, 2016 - Noninvasix
Pancreatic Cancer – Market Insights, Epidemiology and Market Forecast-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for... - April 13, 2016 - DelveInsight
NICE Provides Positive Guidance on electroCore’s gammaCore Treatment for the Prevention and Acute Treatment of Migraine and Cluster Headache
The UK’s National Institute of Health and Care Excellence (NICE) has published guidance that electroCore’s non-invasive vagus nerve stimulation treatment (gammaCore) for the prevention and acute treatment of migraine and cluster headache is safe and can now be used in the NHS. The... - April 09, 2016 - electroCore
FriendsSalonNSpa.ca Announces a Reduction in the Prices of Popular Botox and Juvederm Filler
Botox and fillers that are a proven way to eliminate one's facial wrinkles and fine lines in minutes are now offered at a discount online. - April 07, 2016 - Friends Salon N Spa
For Healthcare Majority, Digital Health Elevates Patient Experience, Curbs Readmissions
For most digital health adopters, the technologies use heightens patient satisfaction and reduces hospital readmissions, according to 2016 market data from the Healthcare Intelligence Network (HIN). - April 07, 2016 - Healthcare Intelligence Network
ValueCentric Expands Specialty Data Quality and Performance Measurement Reporting Capabilities
Dashboards and reports are now available to Specialty manufacturer clients through the ValueTrak Platform. - April 07, 2016 - ValueCentric
ALPCO's New Chemiluminescent IL-6 ELISA Delivers Flexibility and Cost Savings
ALPCO announced the launch of its new STELLUX® Chemi Human IL-6 ELISA - the first cytokine assay in the STELLUX® Chemiluminescence product line. - April 06, 2016 - ALPCO
Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Size Forecast-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 30, 2016 - DelveInsight
Global Medical Solutions to Sell China Operations to Yantai Dongcheng Biochemicals
Global Medical Solutions to sell China Operations to Yantai Dongcheng Biochemicals and enter into a long-term collaborative partnership in China. - March 28, 2016 - Global Medical Solutions
AXSource Global Launches an Enhanced ERP Solution for Life Sciences Companies
AXOQCS™ is complete business solution developed for Microsoft Dynamics AX that provides quality and compliance functionality. Pharmaceutical and Medical Devices manufacturers need a solution that is flexible, responsive, and integrated. AXOQCS™ is a unique ERP solution for Pharma and Life Sciences manufacturers that streamlines and integrates quality and compliance processes, helping them comply with FDA Good Manufacturing Practices while maintaining efficiency and profitability across business. - March 26, 2016 - AxSource
Hematogenix Laboratory Services, LLC Announces the Availability of FDA Approved PD-L1 Companion Diagnostic Tests
Hematogenix Laboratory Services Announces the Availability of PD-L1 Companion Diagnostic Tests for KEYTRUDA®, Merck's Anti-PD-1 Therapy for Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression on or after Platinum-Containing Chemotherapy as well as a PD-L1 Complementary Diagnostic Test to Support Bristol-Myers Squibb's OPDIVO® Anti-PD-1 Therapy for Non-Squamous Non-Small Cell Lung Cancer. - March 24, 2016 - Hematogenix
New York Start-Up Launches Healthy, Clean Nutrition Bar
New Nutrition Bar Shuns Added Sugars, Sweeteners, GMOs; Says Good-Bye to Gluten - March 24, 2016 - Golda Bar
The Gut Health Protocol - Natural Solutions for Nagging Gut Issues, All Backed by Scientific Research
Are you plagued by stomach and intestinal issues, acid reflux, diarrhea, constipation, brain fog? Have you been to several doctors and haven’t seen any long term relief? This was author John Herron a few years ago. Herron decided to research the medical studies himself. What he found was stunning, there are solutions out there, but because they’re natural doctors don’t prescribe them. Now all of this is in the book, “The Gut Health Protocol.” - March 24, 2016 - The Gut Health Protocol
New Bioreactor Tubing Kits from AdvantaPure(R) Speed Turnaround and Increase Processing Capacity; Single-Use and Customizable for Benchtop Bioreactors
Custom, Single-Use Bioreactor Tubing Kits, new from AdvantaPure, contain tubing, filters and connectors for harvest, vent, sparge and addition lines used in benchtop bioreactors. Because the kits arrive preassembled, they provide quicker turnaround time, convenience and less chance of cross contamination. Platinum-cured silicone or AdvantaFlex(R) TPE tubing may be selected as the tubing components in each kit. This product will be exhibited at Interphex booth 3055. - March 24, 2016 - AdvantaPure
Low T St. Louis Opens St. Peters' Location
Local testosterone medical practice to open 11 additional diagnostic lab locations. - March 20, 2016 - Low T St. Louis
Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast - 2010-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 19, 2016 - DelveInsight
Acute Myeloid Leukemia (AML) - Market Insights, Epidemiology and Market Forecast- 2010-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 18, 2016 - DelveInsight
Respiratory Syncytial Virus (RSV) Infections-Market Insights, Epidemiology and Market Forecast-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 17, 2016 - DelveInsight
Multiple Myeloma - Market Insights, Epidemiology and Market Forecast- 2010-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 16, 2016 - DelveInsight
Source-Omega Grows as DHA Private Labeler of Registered Ingredient SOURCE OIL® from Chromista
Source-Omega announces many new 3rd party DHA omega-3 supplement private labels approved to launch in the first half of 2016. Several of the new DHA products seek to benefit prenatal, pregnant and nursing markets in the USA, China and Singapore. SOURCE OIL® is a water extracted DHA algae oil... - March 14, 2016 - Source-Omega
Tabula Rasa HealthCare CIO Receives 2016 Executive Management Award
Tabula Rasa HealthCare CIO Joseph J. Filippoli was honored by SmartCEO Magazine with the 2016 Executive Management Award at a gala celebration March 8. The award recognizes the "leadership and accomplishments of Philadelphia's management all-stars. Winners are recognized for their creative management vision, leadership philosophy, innovative strategy and undeniable work ethic." - March 11, 2016 - Tabula Rasa HealthCare
A Tale of Two New Hepatitis C Drugs
Despite discount, Merck’s just approved Zepatier unlikely to win share with most US payers, except in Medicaid, according to RxScorecard™. New combo from Gilead could ensure company’s dominant position among US payers. - March 11, 2016 - Real Endpoints
April 5, 2016 Webinar to Offer Organizational Readiness Assessment for Next Generation ACO Participation
Two thought leaders in value-based reimbursement strategy will outline a roadmap to readiness for CMS's Next Generation ACO and other risk-based payment models during an April 5, 2016 webinar sponsored by the Healthcare Intelligence Network. - March 11, 2016 - Healthcare Intelligence Network
AdvantaPure(R) Introduces BioClosure(R) System Assemblies That Reduce Assembly Time, Protect Product Integrity and Decrease Contamination Risks
Single-Use components supplier AdvantaPure announces the availability of BioClosure System Assemblies. The ready-to-use, closed container systems are designed to save customers time and expense in their bioprocess applications by eliminating cleaning validations, reducing the need for multiple inventoried parts, and assembling onsite. The Single-Use assemblies also help decrease contamination risks. Applications include aseptic sampling, cell growth, filling, process R&D and cold storage. - March 10, 2016 - AdvantaPure
Population Health Management Needs Fueling Data Analytics Frenzy, Survey Finds
A passion to improve population health is the top driver behind healthcare's dive into data analytics, according to 2016 Data Analytics and Integration metrics from the Healthcare Intelligence Network (HIN). - March 09, 2016 - Healthcare Intelligence Network
Makers Nutrition Launches Premium Stock Formulas
Fast-Growing Nutraceutical Company Offers Nine Popular Stock Formulas to Vitamin and Supplement Businesses - March 08, 2016 - Makers Nutrition, LLC
Stem Cell Oncology – Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Stem Cell Oncology –Pipeline Insights, 2016 to its portfolio. With this launch, DelveInsight now has 700+ Reports on Indication Pipeline Insight. In addition to this, DelveInsight’s research expertise provides the clients with up to date information of market till date order has been placed. - March 08, 2016 - DelveInsight
Friends Salon N Spa Offers Phyto Sintesi Lifting Serum at a Discount on Online Purchase
Experience beautiful, tighter skin by using the innovative Phyto Sintesi Lifting Serum comprising several natural active ingredients. Overcome the signs of premature aging with the power of vegetal extracts, caffeine and vitamins. The serum is offered at a discount now. - March 04, 2016 - Friends Salon N Spa
March 31, 2016 Webinar: U.S.'s Largest Commercial Episodes of Care Payor on Payor-Provider Partnership That Improved Clinical Outcomes & Reduced Total Cost of Care
Horizon Blue Cross Blue Shield New Jersey (BCBSNJ) will outline the value-based payor-provider partnership that yielded $3 million in shared savings in 2014 for 51 participating specialty practices during a March 31, 2016 webinar sponsored by the Healthcare Intelligence Network. - March 03, 2016 - Healthcare Intelligence Network
Indication-Market Insights, Epidemiology and Market Forecast - 2010-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 03, 2016 - DelveInsight
Silver Wolf Nutrition Launches Effective New Protein Powder Made from Peas
Silver Wolf Nutrition has launched a new type of protein powder made exclusively from peas. The product offers 30 grams of protein in a relatively small amount of powder, giving people a vegan, cost-effective, and hypoallergenic solution to their diet and muscle building needs. - March 02, 2016 - Silver Wolf Nutrition
Ixogel®: Agreement on Special Protocol Assessment (SPA) by the US Food and Drug Administration for the Prevention of Lyme Disease
Ixodes AG, a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention of Lyme Disease, today announced that the company has reached agreement with the US Food and Drug Administration (FDA) on the phase III protocol according to the Special Protocol... - March 01, 2016 - Ixodes AG
March 29, 2016 Webinar Will Measure and Evaluate the Impact of Home Visits for Clinically Complex Patients
Community Care of North Carolina will describe the framework and impact of its technology-driven post-discharge home visit intervention for clinically complex Medicaid patients during a March 29, 2016 webinar sponsored by the Healthcare Intelligence Network. - February 29, 2016 - Healthcare Intelligence Network
Speaking of NEC Podcast Retrospective Launches February 28
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant NEC experts - neonatologists, clinicians and researchers - that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - February 27, 2016 - The Morgan Leary Vaughan Fund, Inc.
The Addictions Academy Offers Free Training to Drug Torn Liberty City
The Addictions Academy and Cali Estes offers a free intervention training to an advocate in Liberty City to assist with the drug epidemic in an area where resources are limited. - February 26, 2016 - The Addictions Academy
Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016
DelveInsight, the leading market research and consulting company has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016” to its portfolio. - February 26, 2016 - DelveInsight